
Cambodia Unveils Groundbreaking HIV Prevention Injection: A Game Changer in the Fight Against HIV
2025-06-30
Author: Yu
Cambodia Takes a Bold Step in HIV Prevention
In a historic move, the Cambodian Ministry of Health announced the launch of Cabotegravir, a revolutionary injectable medication aimed at preventing HIV infections, on June 27. This makes Cambodia the first country in the Asia-Pacific region to offer such an innovative solution.
Revolutionary Injection Offers Long-Lasting Protection
Cabotegravir, administered via a single injection every two months, promises durable protection against HIV, making it an ideal option for those at high risk, including female sex workers, transgender individuals, men who have sex with men, and intravenous drug users. With a staggering effectiveness rate of up to 95%, CAB-PrEP emerges as a life-saving alternative to daily oral prevention pills.
A New Hope for At-Risk Populations
The introduction of Cabotegravir is a significant advancement in Cambodia's comprehensive strategy to combat HIV/AIDS. During the official launch, Health Ministry Secretary of State Youk Sambath highlighted that this rollout offers multiple protection options, enhancing privacy and accessibility for vulnerable populations.
International Praise and Support
The event also garnered international attention, with Patricia Ongpin, the UNAIDS country director for Cambodia, Laos, and Malaysia, in attendance. UNAIDS applauded the launch as a "historic milestone" in the nation’s ongoing battle against HIV.
Looking Ahead: The Dapivirine Vaginal Ring
But the innovations don’t stop there! Cambodia is set to roll out the Dapivirine Vaginal Ring (DVR) soon, another long-acting HIV prevention method tailored specifically for women, promising to further broaden the horizons of HIV prevention.
The Current HIV Landscape in Cambodia
Although 76,000 individuals are currently living with HIV in Cambodia, and with new infections primarily affecting young men aged 15-24, the nation is making remarkable strides. The HIV prevalence rate in the general population stands at a low 0.5%.
Commitment to the 95-95-95 Goals
Cambodia is also committed to meeting the global 95-95-95 strategy goals for HIV/AIDS. An impressive 92% of people living with HIV are aware of their status, and virtually all diagnosed individuals are on treatment, with over 98% achieving viral suppression. Since 2010, new HIV infections have plummeted by 45%, exceeding the global average.
A Landmark Moment in Public Health
This monumental launch not only highlights Cambodia's leadership in public health innovations but also offers new hope in the fight against one of the world's deadliest epidemics. With the combined efforts of the Cambodian government and international organizations like UNAIDS, the future looks brighter for at-risk populations.